Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial
Authors: Ambrosy, Andrew P | Heart Failure Reviews | September 1, 2024 | PubMed abstract
Copyright © 2025 The Permanente Medical Group. All rights reserved.